JP2001505553A5 - - Google Patents

Download PDF

Info

Publication number
JP2001505553A5
JP2001505553A5 JP1998521419A JP52141998A JP2001505553A5 JP 2001505553 A5 JP2001505553 A5 JP 2001505553A5 JP 1998521419 A JP1998521419 A JP 1998521419A JP 52141998 A JP52141998 A JP 52141998A JP 2001505553 A5 JP2001505553 A5 JP 2001505553A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP1998521419A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001505553A (ja
Filing date
Publication date
Priority claimed from US08/744,367 external-priority patent/US6159952A/en
Application filed filed Critical
Publication of JP2001505553A publication Critical patent/JP2001505553A/ja
Publication of JP2001505553A5 publication Critical patent/JP2001505553A5/ja
Pending legal-status Critical Current

Links

JP52141998A 1996-11-07 1997-10-21 ウリジン三リン酸および関連化合物で気管支炎を治療する方法 Pending JP2001505553A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/744,367 US6159952A (en) 1996-11-07 1996-11-07 Method of treating bronchitis with uridine triphosphate and related compounds
US08/744,367 1996-11-07
PCT/US1997/018766 WO1998019685A1 (en) 1996-11-07 1997-10-21 Method of treating bronchitis with uridine triphosphates and related compounds

Publications (2)

Publication Number Publication Date
JP2001505553A JP2001505553A (ja) 2001-04-24
JP2001505553A5 true JP2001505553A5 (https=) 2005-06-16

Family

ID=24992452

Family Applications (1)

Application Number Title Priority Date Filing Date
JP52141998A Pending JP2001505553A (ja) 1996-11-07 1997-10-21 ウリジン三リン酸および関連化合物で気管支炎を治療する方法

Country Status (14)

Country Link
US (1) US6159952A (https=)
EP (1) EP0941099B1 (https=)
JP (1) JP2001505553A (https=)
KR (1) KR100518066B1 (https=)
CN (1) CN1115152C (https=)
AT (1) ATE249833T1 (https=)
AU (1) AU744981B2 (https=)
BR (1) BR9714312A (https=)
CA (1) CA2271126C (https=)
DE (1) DE69724991T2 (https=)
ES (1) ES2207723T3 (https=)
NO (1) NO992197L (https=)
NZ (1) NZ335540A (https=)
WO (1) WO1998019685A1 (https=)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968913A (en) * 1996-07-03 1999-10-19 Inspire Pharmaceuticals, Inc. Pharmaceutical compositions of uridine triphosphate
US6319908B1 (en) 1996-07-03 2001-11-20 Inspire Pharmaceuticals, Inc. Method for large-scale production of di(uridine 5′-tetraphosphate) and salts thereof
US5763447C1 (en) 1996-07-23 2002-05-07 Inspire Pharmaceuticals Method of preventing or treating pneumonia in immobilized patients with uridine triphosphates and related compounds
US6872710B2 (en) * 1997-07-25 2005-03-29 Inspire Pharmaceuticals, Inc. Di(uridine 5′)-tetraphosphate and salts thereof
WO1999005155A2 (en) 1997-07-25 1999-02-04 Inspire Pharmaceuticals, Inc. Salts of di(uridine 5'-tetraphosphate), method for preparation and uses thereof
TW593331B (en) 1997-07-25 2004-06-21 Inspire Pharmaceuticals Inc Method for large-scale production of di(uridine 5')-tetraphosphate and salts thereof
US6251693B1 (en) 1998-07-30 2001-06-26 Micron Technology, Inc. Semiconductor processing methods and semiconductor defect detection methods
DE60015734D1 (de) * 1999-02-26 2004-12-16 Inspire Pharmaceuticals Durham Verwendung von dinukleotidtriphosphaten, cytidindiphosphaten und adenindiphosphaten zur herstellung einer pharmazeutischen zubereitung zur förderung der schleimauthydratation
US7018985B1 (en) 2000-08-21 2006-03-28 Inspire Pharmaceuticals, Inc. Composition and method for inhibiting platelet aggregation
US7452870B2 (en) * 2000-08-21 2008-11-18 Inspire Pharmaceuticals, Inc. Drug-eluting stents coated with P2Y12 receptor antagonist compound
US6555675B2 (en) 2000-08-21 2003-04-29 Inspire Pharmaceuticals, Inc. Dinucleoside polyphosphate compositions and their therapuetic use as purinergic receptor agonists
US6867199B2 (en) 2000-08-21 2005-03-15 Inspire Pharmaceuticals, Inc. Dinucleoside polyphosphate compositions and their therapeutic use
JP2005508297A (ja) 2001-06-25 2005-03-31 インスパイアー ファーマシューティカルズ,インコーポレイティド P2yプリン受容体作用物質による関節潤滑
JP2005532254A (ja) * 2001-11-06 2005-10-27 インスパイアー ファーマシューティカルズ,インコーポレイティド 炎症性疾患を治療又は予防する方法
JP2006505585A (ja) * 2002-10-18 2006-02-16 モリケム メディシンズ, インコーポレイテッド ランチビオティクスで眼乾燥症を処置する方法
WO2005107787A1 (en) * 2004-05-06 2005-11-17 Molichem Medicines, Inc. Treatment of membrane-associated diseases and disorders using lantibiotic containing compositions
EP1753445A4 (en) * 2004-05-06 2009-05-20 Molichem Medicines Inc TREATMENT OF EYE DISEASES AND EYE TREATMENTS WITH LANTIBIOTIC COMPOSITIONS
US7368439B2 (en) * 2005-06-15 2008-05-06 Bar - Ilan University Dinucleoside poly(borano)phosphate derivatives and uses thereof
US7851456B2 (en) * 2005-06-29 2010-12-14 Inspire Pharmaceuticals, Inc. P2Y6 receptor agonists for treating lung diseases
US20070249556A1 (en) * 2006-04-21 2007-10-25 Brubaker Kurt E Method of treating inflammation
JP2011026204A (ja) * 2007-11-26 2011-02-10 Rei Furukawa タバコの煙を吸入することにより引き起こされる疾患の予防及び/又は治療用組成物
WO2019112383A1 (ko) * 2017-12-08 2019-06-13 윤주석 금속 미네랄 디아미네이트 및 이의 제조방법

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2122529A1 (de) * 1971-05-06 1972-12-14 Max Planck Gesellschaft zur Förde rung der Wissenschaften e V , 3400 Gottin gen Thiophosphatanaloge der Nucleosid di und tnphosphate sowie Verfahren zu ihrer Herstellung
US3960840A (en) * 1972-12-29 1976-06-01 University Of Illinois Foundaton Fluorescent derivatives of adenine-containing compounds
US4501729A (en) * 1982-12-13 1985-02-26 Research Corporation Aerosolized amiloride treatment of retained pulmonary secretions
GB9027968D0 (en) * 1990-12-22 1991-02-13 Fisons Plc Method of treatment
JP3141028B2 (ja) * 1991-04-06 2001-03-05 アストラ・フアーマシユウテイカルズ・リミテツド Atp類似体
FR2684299B1 (fr) * 1991-12-02 1995-03-24 Synthelabo Compositions pharmaceutiques contenant de l'adenosine-5-triphosphate disodique et de l'amiloride.
EP0517573A1 (fr) * 1991-06-05 1992-12-09 Synthelabo Compositions pharmaceutiques pour le traitement des affections des voies respiratoires
FR2677250B1 (fr) * 1991-06-05 1995-01-20 Synthelabo Compositions pharmaceutiques contenant de l'adenosine-5-triphosphate disodique.
US5292498A (en) * 1991-06-19 1994-03-08 The University Of North Carolina At Chapel Hill Method of treating lung disease with uridine triphosphates
US5635160A (en) * 1995-06-07 1997-06-03 The University Of North Carolina At Chapel Hill Dinucleotides useful for the treatment of cystic fibrosis and for hydrating mucus secretions
US5628984A (en) * 1995-07-31 1997-05-13 University Of North Carolina At Chapel Hill Method of detecting lung disease

Similar Documents

Publication Publication Date Title
JP2001504279A5 (https=)
JP2001507599A5 (https=)
JP2000514320A5 (https=)
JP2001507576A5 (https=)
JP2001501023A5 (https=)
JP2001511216A5 (https=)
JP2000513608A5 (https=)
JP2000506623A5 (https=)
JP2001507643A5 (https=)
JP2000514461A5 (https=)
JP2001506303A5 (https=)
JP2000503406A5 (https=)
JP2001506386A5 (https=)
JP2001506451A5 (https=)
JP2000514722A5 (https=)
JP2000517129A5 (https=)
JP2000516585A5 (https=)
JP2000515542A5 (https=)
JP2000506084A5 (https=)
JP2000514109A5 (https=)
JP2000515003A5 (https=)
JP2000504607A5 (https=)
JP2000516272A5 (https=)
JP2001501019A5 (https=)
JP2001500557A5 (https=)